The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
The levels of total and l-tartrate labile acid phosphatase were studied in 49 patients with prostatic carcinoma. The results were compared with the results from a control group. The acid phosphatase levels from the bone marrow were above the upper normal limit of serum acid phosphatase both in the control group and in patients with prostatic carcinoma. This may be due to acid phosphatase released from blood cells during haemolysis. There was a positive correlation between serum and bone marrow acid phosphatase levels in patients with prostatic carcinoma. Significantly raised levels of bone marrow acid phosphatase (above the upper limit of the normal range from the control group) were observed only in advanced stage IV patients with significantly increased serum levels. The levels of bone marrow acid phosphatase gave no supplementary diagnostic information in any of the patients with prostatic carcinoma. Doubt is expressed concerning the hypothesis that raised levels of bone marrow acid phosphatase are diagnostic of early metastases from prostatic carcinoma.
D000135:Acid Phosphatase / Q000097:blood / Q000378:metabolism*; D001853:Bone Marrow / Q000201:enzymology*; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000201:enzymology; D006461:Hemolysis; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000201:enzymology*
D000135:Acid Phosphatase